Highlights and Quick Summary
- Annual 3Y Operating Income Growth (CAGR) for 2021 was 0.0% (a NaN% decrease from previous year)
- Annual 3Y Operating Income Growth (CAGR) for 2020 was 0.0% (a NaN% decrease from previous year)
- Annual 3Y Operating Income Growth (CAGR) for 2018 was 0.0% (a NaN% decrease from previous year)
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 3Y Operating Income Growth (CAGR) of BridgeBio Pharma, Inc.
Most recent 3Y Operating Income Growth (CAGR)of BBIO including historical data for past 10 years.Interactive Chart of 3Y Operating Income Growth (CAGR) of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. 3Y Operating Income Growth (CAGR) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | 0.0% |
| 2020 | – | – | – | – | 0.0% |
| 2018 | – | – | – | – | 0.0% |
| 2017 | – | – | – | – | 0.0% |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology